Therapeutic Apheresis and Dialysis

Papers
(The H4-Index of Therapeutic Apheresis and Dialysis is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis29
Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open‐label study in Japan18
The scientific basis and future of lipoprotein apheresis18
Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study16
Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indications16
Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically‐ill COVID‐19 patients16
Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A meta‐analysis of randomized controlled trials15
A COVID‐19 pandemic‐specific, structured care process for peritoneal dialysis patients facilitated by telemedicine: Therapy continuity, prevention, and complications management15
Effectiveness of SARS‐CoV‐2 vaccines on hemodialysis patients in Japan: A nationwide cohort study13
Two long‐term phase 3 studies of enarodustat (JTZ‐951) in Japanese anemic patients with chronic kidney disease not on dialysis or on maintenance hemodialysis: SYMPHONY ND‐Long an12
Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patients12
A novel low‐density lipoprotein/fibrinogen apheresis method for chronic limb‐threatening ischemia in patients with poor options for revascularization: A multicenter, single‐arm clinical trial12
Renal replacement therapy for critically ill patients with COVID‐19‐associated acute kidney injury: A review of current knowledge12
Hyperkalemia in patients undergoing hemodialysis: Its pathophysiology and management12
0.049636840820312